Saturday 17 October 2026 Export ALNY’s income statement to Excel — free account

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, up 65.2% from fiscal 2024. In the quarter to June 2026, revenue grew 66.9%, EPS grew 341.2%, free cash flow grew 152.8% and total debt fell 1.51%, each against the same quarter a year earlier. Member of the Nasdaq 100; revenue growth for five consecutive years.

231.83 2.20 −0.94%

Follow ALNY

Alert me

Market cap: $31.3B
P/E: 39.5×
Fwd P/E: 39.6×
Dividend yield: —
F-score: 6/9
Altman Z: 7.30
Beneish M: −1.95
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	748.40	163.12	80.14	51.30
P/S ratio Full definition →		18.67	14.03	10.26	8.37
P/FCF ratio Full definition →		270.78	111.94	68.35	49.06
P/Operating CF Full definition →		170.75	318.51	623.66	123.10
P/B ratio Full definition →		256.27	66.01	40.89	29.70
Price to Tangible BV Full definition →		256.27	66.01	40.89	29.70
EV/Sales Full definition →		18.15	13.51	9.79	7.89
EV/EBITDA Full definition →		181.47	90.08	52.01	35.96
EV/Operating CF Full definition →		219.12	95.77	58.71	41.59
EV/FCF Full definition →		263.17	107.85	65.24	46.25
Quick Ratio Full definition →		2.37	2.51	2.89	2.79
Current Ratio Full definition →		2.54	2.76	3.13	3.05
Net Debt/EBITDA Full definition →		(4.41)	(13.09)	(7.09)	(9.36)
Debt/Assets Full definition →		21.44%	20.29%	19.68%	18.19%
Debt/Equity Full definition →		4.45	1.28	0.94	0.75
Asset Turnover Full definition →		0.71	0.81	0.92	0.95
Operating CF/Net income Full definition →		1.40	1.07	0.34	1.99
Capex/Depreciation Full definition →		(0.88)	(1.72)	(1.61)	(2.50)
Interest Coverage Full definition →		8.29	1.49	3.88	2.82
Research and Development Expense of Revenue Full definition →		28.73%	33.93%	31.26%	32.00%
Selling, General and Administrative Expense of Revenue Full definition →		25.79%	29.66%	27.64%	26.95%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		8.66%	6.53%	6.01%	6.71%
Graham Net Nets Full definition →		(0.01)	0.00	0.00	0.01
Graham Number Full definition →		4.94	18.18	27.42	36.58
Earnings Yield Full definition →		0.13%	0.61%	1.25%	1.95%
Free Cash Flow Yield Full definition →		0.37%	0.89%	1.46%	2.04%
Revenue per Share Full definition →		9.50	8.37	8.78	9.66
Operating CF per Share Full definition →		2.67	1.25	0.53	2.45
Capex per Share Full definition →		(0.09)	(0.18)	(0.16)	(0.26)
Free Cash Flow per Share Full definition →		2.58	1.07	0.37	2.19
Cash per Share Full definition →		20.73	22.20	22.64	24.76
Shareholders Equity per Share Full definition →		1.78	6.02	8.09	10.14
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		1.78	6.02	8.09	10.14
Free Cash Flow Full definition →		338.89	140.26	48.67	292.04
Working Capital Full definition →		2,397.33	2,584.31	2,869.83	3,107.66
Capital Expenditures Full definition →		(12.14)	(23.29)	(21.83)	(34.68)
Net Current Asset Value Full definition →		(664.96)	(126.49)	165.14	415.52
EV/EBIT Full definition →		220.08	100.07	55.80	37.93
Capex to Sales Full definition →		0.01	0.02	0.02	0.03
Price to Operating Income Full definition →		226.44	103.86	58.46	40.23
Other line items
Average Receivables Full definition →		659.31	591.44	651.00	739.93
Average Payables Full definition →		94.20	102.07	112.01	105.20
Average Inventory Full definition →		75.69	80.61	74.80	84.40
Average Assets Full definition →		4,528.35	4,603.16	4,671.68	5,062.39
Average Common Equity Full definition →		133.12	428.13	595.41	802.35

Show all line items

Columns are period end dates

Stockrow Weekly